Levemir
Product Images NDC 68258-8977

23 FDA label images from Dispensing Solutions, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Levemir (NDC 68258-8977). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure Of Chemical Structure (508a5c51 862e 43ac 84a4 31c5adfd5ec3 01)

Figure Of Chemical Structure (508a5c51 862e 43ac 84a4 31c5adfd5ec3 01)
Chemical structure diagram showing the amino acid sequences and disulfide bonds of the active ingredient in Levemir by Dispensing Solutions, Inc. The structure includes labeled cysteine residues linked by sulfur atoms and a fatty acid side chain, corresponding to the insulin analog's modified peptide chain.*
FDA Label Image

Figure 1: Activity Profiles In Patients With Type 1 Diabetes In A 24-hour Glucose Clamp Study (508a5c51 862e 43ac 84a4 31c5adfd5ec3 02)

Figure 1: Activity Profiles In Patients With Type 1 Diabetes In A 24-hour Glucose Clamp Study (508a5c51 862e 43ac 84a4 31c5adfd5ec3 02)
A pharmacodynamic line graph showing glucose infusion rate (mg/kg/min) over 24 hours following insulin injection, comparing Levemir at 0.2 and 0.4 U/kg doses with NPH at 0.3 U/kg. Includes a table of pharmacodynamic parameters (AUC and GIRmax) for each insulin type and dose.*
FDA Label Image

Figure 2: Activity Profiles In Patients With Type 2 Diabetes In A 16-hour Glucose Clamp Study (508a5c51 862e 43ac 84a4 31c5adfd5ec3 03)

Figure 2: Activity Profiles In Patients With Type 2 Diabetes In A 16-hour Glucose Clamp Study (508a5c51 862e 43ac 84a4 31c5adfd5ec3 03)
A line graph showing glucose infusion rate (mg/kg/min) over time (hours) after insulin injection, comparing Levemir (IDet) at 0.6 and 1.2 IU/kg doses with NPH insulin at the same doses. The chart illustrates pharmacodynamic parameters and glucose infusion rate profiles over 16 hours post-injection.*
FDA Label Image

Figure Of Innolet And Needles (508a5c51 862e 43ac 84a4 31c5adfd5ec3 04)

Figure Of Innolet And Needles (508a5c51 862e 43ac 84a4 31c5adfd5ec3 04)
An instructional diagram of the InnoLet insulin delivery pen components and features. It includes labeled illustrations of the dose selector dial with push-button, dose scale, compartment for needles, pen cap, insulin cartridge with residual scale and rubber membrane, needle, inner needle cap, and big outer needle cap. This diagram visually explains the pen's parts and assembly for insulin administration.*
FDA Label Image

Figure 1a: Attaching Needle To Innolet (508a5c51 862e 43ac 84a4 31c5adfd5ec3 05)

Figure 1a: Attaching Needle To Innolet (508a5c51 862e 43ac 84a4 31c5adfd5ec3 05)
An instructional illustration showing the top of a Levemir insulin pen with an arrow indicating the motion to turn or twist the dial or cap, likely part of the usage steps for preparing the pen for injection.*
FDA Label Image

Figure 1b: Doing The Air Shot (508a5c51 862e 43ac 84a4 31c5adfd5ec3 06)

Figure 1b: Doing The Air Shot (508a5c51 862e 43ac 84a4 31c5adfd5ec3 06)
An instructional illustration showing a hand holding a Levemir insulin pen with a dosing scale visible on the pen. The instruction panel beside the pen likely provides steps or guidance for dose adjustment or injection technique.*
FDA Label Image

Figure 2: Setting The Dose (508a5c51 862e 43ac 84a4 31c5adfd5ec3 07)

Figure 2: Setting The Dose (508a5c51 862e 43ac 84a4 31c5adfd5ec3 07)
An instructional diagram depicting a circular dial or knob with numeric markings from 0 to 50 in increments of 5. Two curved arrows indicate rotation directions around the dial, illustrating how to turn the knob between specific numeric positions.*
FDA Label Image

Figure 3: Giving The Injection (508a5c51 862e 43ac 84a4 31c5adfd5ec3 08)

Figure 3: Giving The Injection (508a5c51 862e 43ac 84a4 31c5adfd5ec3 08)
An instructional illustration showing how to set the dose on a Levemir insulin pen. The image depicts a hand adjusting the dial to select the correct dosage, with a downward arrow indicating pressing the dose button to inject the insulin through the needle at the bottom.*
FDA Label Image

Figure Of Doing The Function Check (508a5c51 862e 43ac 84a4 31c5adfd5ec3 09)

Figure Of Doing The Function Check (508a5c51 862e 43ac 84a4 31c5adfd5ec3 09)
An instructional diagram showing a close-up of an insulin pen needle cap or tip, labeled with the number 20, and part of a dial indicating dosage units, ranging from 25 to over 35 units. The image likely relates to dose setting or needle attachment for an insulin delivery device.*
FDA Label Image

Figure Of Levemir Flexpen And Needle (508a5c51 862e 43ac 84a4 31c5adfd5ec3 10)

Figure Of Levemir Flexpen And Needle (508a5c51 862e 43ac 84a4 31c5adfd5ec3 10)
Illustration showing components of the Levemir FlexPen by Dispensing Solutions, Inc., including the pen cap, rubber stopper, cartridge with scale, pointer, dose selector, and push-button. Also depicted are parts of the NovoFine needle: big outer needle cap, inner needle cap, needle, and protective tab.*
FDA Label Image

Diagram A: Pull The Cap Off The Flexpen (508a5c51 862e 43ac 84a4 31c5adfd5ec3 11)

Diagram A: Pull The Cap Off The Flexpen (508a5c51 862e 43ac 84a4 31c5adfd5ec3 11)
An instructional illustration showing a close-up of hands holding a pen-like medical device, with an arrow indicating a part of the device being turned or adjusted. This likely demonstrates a step in preparing the device for use.*
FDA Label Image

Diagram B: Attaching The Needle To Flexpen (508a5c51 862e 43ac 84a4 31c5adfd5ec3 12)

Diagram B: Attaching The Needle To Flexpen (508a5c51 862e 43ac 84a4 31c5adfd5ec3 12)
Instructional diagram showing a hand holding a Levemir insulin pen and twisting the dial or cap, indicating how to prepare or adjust the pen for use.*
FDA Label Image

Diagram C: Removing The Big Outer Needle Cap (508a5c51 862e 43ac 84a4 31c5adfd5ec3 13)

Diagram C: Removing The Big Outer Needle Cap (508a5c51 862e 43ac 84a4 31c5adfd5ec3 13)
An instructional illustration showing two hands connecting a needle to a syringe or pen injector. A blue arrow indicates the direction to push the needle onto the device, demonstrating proper assembly technique for drug administration.*
FDA Label Image

Diagram D: Removing The Inner Needle Cap (508a5c51 862e 43ac 84a4 31c5adfd5ec3 14)

Diagram D: Removing The Inner Needle Cap (508a5c51 862e 43ac 84a4 31c5adfd5ec3 14)
An instructional illustration showing the preparation of a Levemir insulin pen device. It depicts a hand holding and removing a transparent cap from the pen's needle, indicated by a blue arrow pointing away from the pen.*
FDA Label Image

Diagram E: Selecting The Dose For The Air Shot (508a5c51 862e 43ac 84a4 31c5adfd5ec3 15)

Diagram E: Selecting The Dose For The Air Shot (508a5c51 862e 43ac 84a4 31c5adfd5ec3 15)
An instructional illustration showing a close-up of a hand adjusting the dose on a Levemir insulin pen injector, with an inset highlighting the dial indicating 2 units selected. The image demonstrates how to set the injection dose using the pen's dosing mechanism.*
FDA Label Image

Diagram F: Tap The Cartridge To Move Air To Top Of Cartridge (508a5c51 862e 43ac 84a4 31c5adfd5ec3 16)

Diagram F: Tap The Cartridge To Move Air To Top Of Cartridge (508a5c51 862e 43ac 84a4 31c5adfd5ec3 16)
An instructional illustration showing a hand pressing down on the plunger of a Levemir insulin pen. The image highlights the injection button being pressed, likely indicating the administration step in using the Levemir pen.*
FDA Label Image

Diagram G: Point Needle Upwards And Press The Push-button (508a5c51 862e 43ac 84a4 31c5adfd5ec3 17)

Diagram G: Point Needle Upwards And Press The Push-button (508a5c51 862e 43ac 84a4 31c5adfd5ec3 17)
An instructional illustration shows a hand pulling off the outer needle cover from an injection pen by lifting it upward. A smaller inset image depicts the outer needle cover completely removed from the pen, illustrating the correct technique for needle preparation before injection.*
FDA Label Image

Diagram H: Selecting Your Dose (508a5c51 862e 43ac 84a4 31c5adfd5ec3 18)

Diagram H: Selecting Your Dose (508a5c51 862e 43ac 84a4 31c5adfd5ec3 18)
An instructional illustration depicting a close-up of a hand adjusting a dosage selector on a device, showing options for 5 units and 24 units. The image highlights how to select the dose amount, featuring numeric indicators on the device's dial or screen.*
FDA Label Image

Diagram I: Giving The Injection (508a5c51 862e 43ac 84a4 31c5adfd5ec3 19)

Diagram I: Giving The Injection (508a5c51 862e 43ac 84a4 31c5adfd5ec3 19)
An instructional diagram showing a hand pressing down on the cap of a Levemir insulin vial to remove it. The close-up detail highlights the cap being pulled off vertically from the vial's top.*
FDA Label Image

Diagram J: Keep Needle In Skin For 6 Seconds (508a5c51 862e 43ac 84a4 31c5adfd5ec3 20)

Diagram J: Keep Needle In Skin For 6 Seconds (508a5c51 862e 43ac 84a4 31c5adfd5ec3 20)
An instructional illustration showing an insulin pen device held vertically with a dosing window visible, positioned above a skin surface, depicting the step for subcutaneous injection typically used for Levemir insulin delivery.*
FDA Label Image

Diagram K: Replacing The Pen Cap (508a5c51 862e 43ac 84a4 31c5adfd5ec3 21)

Diagram K: Replacing The Pen Cap (508a5c51 862e 43ac 84a4 31c5adfd5ec3 21)
An instructional illustration showing how to push the blue clip on a device labeled 'K'. The image demonstrates the use of fingers to slide or activate the component.*
FDA Label Image

Diagram L: Figure Of Function Check (508a5c51 862e 43ac 84a4 31c5adfd5ec3 22)

Diagram L: Figure Of Function Check (508a5c51 862e 43ac 84a4 31c5adfd5ec3 22)
An instructional diagram showing the top of a Levemir insulin delivery pen with its needle cap partially removed. The image includes a close-up of the pen’s tip with a measurement marking of 20 on the needle cap, illustrating how to handle or prepare the pen for injection.*
FDA Label Image

Ndc 68258-8977-01 (Ndc 68258 8977 01 Novo Nordisk)

Ndc 68258-8977-01 (Ndc 68258 8977 01      Novo Nordisk)
Label for Levemir 100 units/mL (U-100) insulin detemir injection, 10 mL multiple-dose vial, NDC 68258-8977-01. Manufactured by Novo Nordisk Inc., Princeton, NJ, and packaged exclusively by Dispensing Solutions, Inc., Santa Ana, CA. The label includes active ingredient details, usage instructions, and warnings, emphasizing refrigeration and not mixing with other insulins. It also displays lot, expiration, and prescription number placeholders along with barcodes and a QR code.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.